ValGenesis, Inc., a provider of Enterprise Validation Lifecycle Management Systems (VLMS), was selected by international biosciences company to digitize the validation processes for its products through a single ValGenesis VLMS with multilingual support that would be accessed by thousands of life science organizations across 40 countries.
 
ValGenesis VLMS will digitize the validation service activities this company provides to its clients and the international scientific community for efficient and faster access to validated and safer products. The digitalization of the validation processes for this global biosciences company’s clients will begin across three European countries, followed by implementation across 40 countries.
 
“We are thrilled to work with this biosciences giant in deploying a global, homogenous platform that will be used by thousands of life sciences companies, augmenting true digital transformation in the spirit of Pharma 4.0. ValGenesis VLMS is an end-to-end, digital validation solution that can enable a primary source of truth, thereby ensuring data integrity and adherence to the most stringent global regulatory requirements. We are excited about the journey ahead as we prepare for multiple global rollouts,” says Narayan Raj, Sr. Vice President of Global Sales & Operations at ValGenesis, Inc.